Levofloxacin

Floxel®

Prescription Drug

Indication

For the treatment of adults (≥ 18 years old) with mild, moderate, or severe infections caused by susceptible strains of the designated microorganisms for the following conditions:

• Acute bacterial sinusitis
• Acute bacterial exacerbation of chronic bronchitis
• Community-acquired pneumonia
• Healthcare-associated pneumonia
• Complicated skin and skin structure infections
• Uncomplicated skin and skin structure infections (mild to moderate) including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections
• Complicated urinary tract infections
• Acute pyelonephritis
• Chronic bacterial prostatitis
• Uncomplicated urinary tract infections

To reduce the incidence or progression of inhalational anthrax, following exposure to aerosolized Bacillus anthracis. The effectiveness of levofloxacin is based on plasma concentrations achieved in humans, a surrogate endpoint reasonably likely to predict clinical benefit. Levofloxacin has not been tested in humans for the post-exposure prevention of inhalation anthrax.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.